Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol

Oncogene

Volumn 14, Issue 3, 1997, Pages 379-384

  Mukhopadhyay, Tapas ^a   Roth, Jack A ^a,b  

^a Dept Thorac and Cardiovasc Surg ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Gene expression; Lung cancer; Methoxyestradiol; p53

Indexed keywords

COMPLEMENTARY DNA; ESTRADIOL 3 METHYL ETHER; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; GENE ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031037067     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200835     Document Type: Article

References (27)

1. Aizu-Yokota E, Susaki A and Sato Y. (1995). Cancer Res., 55, 1863-1868.
2. Blagosklonny MV, Toretsky J and Neckers L. (1995). Oncogene, 11, 933-939.
3. Canver CC, Memoli VA, Vanderveer PL, Dingivan CA and Mentzer RM Jr. (1994). J. Thorac. Cardiovasc. Surg., 108, 153-157.
4. Cushman M, He H, Katzenellenbogen JA, Lin CM and Hamel E. (1995). J. Med. Chem., 38, 2041-2049.
5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
6. Elledge RM and Lee W. (1995). BioEssays, 17, 923-930.
7. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP and Schwelgerer L. (1994). Nature, 368, 237-239.
8. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB and Roth JA. (1994). Cancer Res., 54, 2287-2291.
9. Funk WD, Pak DT, Karas RH, Wright WE and Shay JW. (1992). Mol. Cell. Biol., 12, 2866-2871.
10. Hermeking H, Wolf DA, Kohlhuber F, Funk JO, Reichert M, Dickmanns A, Fanning E and Eick D. (1995). Cell Biol. Intl., 19, 705-706.
11. Hurd C, Khattree N, Alban P, Nag K, Jhanwar SC, Dinda S and Moudgil VK. (1995). J. Biol. Chem., 270, 28507-28510.
12. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
13. Lottering M, Haag M and Seegers JC. (1992). Cancer Res., 52, 5926-5932.
14. Maxwell SA, Roth JA and Mukhopadhyay T. (1996). Electrophoresis, (in press).
15. Milner J and Watson JV. (1990). Oncogene, 5, 1683-1690.
16. Mukhopadhyay T, Tainsky M, Cavender AC and Roth JA. (1991). Cancer Res., 51, 1744-1748.
17. Mukhopadhyay T and Roth JA. (1993). Cancer Res., 53, 4362-4366.
18. Mukhopadhyay T, Roth JA and Maxwell SA. (1995). Oncogene, 11, 999-1003.
19. Ryan JJ, Danish R, Gottlieb CA and Clarke MF. (1993). Mol. Cell. Biol., 13, 711-719.
20. Thompson AM, Steel CM, Foster ME, Kerr D, Paterson D, Deane D, Hawkins RA, Carter DC and Evans HJ. (1990). Br. J. Cancer, 62, 78-84.
21. Tishler RB, Lamppu DM, Park S and Price BD. (1995). Cancer Res., 55, 6021-6025.
22. Vogelstein B and Kinzler KW. (1992). Cell, 70, 523-526.
23. Wagner AJ, Kokontis JM and Hay N. (1994). Genes Dev., 8, 2817-2830.
24. Wang TTY and Phang JM. (1995). Cancer Res., 55, 2487-2489.
25. Yonish-Rouach E, Resnitzky D, Rotem J, Sachs L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.
26. Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins JR and May E. (1996). Oncogene, 12, 2197-2205.
27. Zamai L, Falcieri E, Merhefka G and Vitale M. (1996). Cytometry, 23, 303-311.